drugset / Trial / NCT04703361

Effects of Ketones and Niacin in Heart Failure Patients

NCT04703361 ↗

Phase 2 Completed 12 enrolled University of Aarhus
RandomizedCrossoverSingle-blindTreatment

Summary

Ketones, 3-hydroxybutyrate (3-OHB), have shown to have beneficial hemodynamics effect in patients with hearth failure with reduced ejection fraction. The mechanisms behind these marked hemodynamic effects are currently unknown, but could involve prostaglandin-release. 3-OHB is the endogenous ligand for the G protein-coupled receptor hydroxy-carboxylic acid 2 (HCA2) receptor. This receptor has proven downstream effects on cAMP and systemic effects via release of prostaglandins. In this present study we will investigate the cardiovascular effects of HCA2-receptor stimulation in heart failure patients.

Timeline

Start
2021-02-15
Primary completion
2021-09-03
Completion
2021-09-03

Outcome

Mixed primary results

paper The primary end point was CO. 3-OHB increased CO (2.3 L/min, P<0.01) PMID 37301762 ↗

paper Niacin increased prostaglandin D2 levels by 330% (P<0.02) and reduced free fatty acids by 75% (P<0.01) but did not affect CO. PMID 37301762 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Na-3-OHB Unknown — —
Subject Niacin Small molecule — —